Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WMT vs MRNA✓SelectedUSD · MRNAWMT vs MRNA performance historyLatest closeAs of+1.52%11/20
Stock and ETF performance explorer

WMT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+155.1%
MRNA return
+153.9%
Excess return
+1.2%
Maximum drawdown
-23.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.5%-2.2%+3.7%+1.5%
7D-0.1%-12.7%+12.6%-0.1%
30D+8.6%-20.7%+29.3%+8.7%
3M+23.5%+46.3%-22.8%+23.2%
6M-2.0%+305.2%-307.2%-2.6%
YTD+15.6%+561.2%-545.7%+13.5%
1Y+20.5%+772.1%-751.6%+17.6%
3Y+155.1%+147.0%+8.1%+155.9%
All+155.1%+153.9%+1.2%+155.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling